Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia
Shellaina J.V. Gordon, Florian Perner, Laura MacPherson, Katie A. Fennell, Daniela Vanessa Wenge, Wallace Bourgeois, Tabea Klaus, Thomas Plenge, Anelya Murat, Jelena Petrovic, Jakub Horvath, Joan Q. Cao, John D. Lapek, Sean A. Uryu, Jeffrey R. White, , Mark A. Dawson
The paper shows that inhibiting KAT6/KAT7 enhances Menin inhibitor efficacy and overcomes resistance in MLL-FP leukemia.
Cancer Discovery · Jun 19, 2025Peer-reviewedCancer Biology